Adage Capital Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$880M Buy
956,817
+124,525
+15% +$126M 1.36% 10
2025
Q4
$894M Buy
832,292
+25,426
+3% +$24.3M 1.35% 10
2025
Q3
$616M Sell
806,866
-34,944
-4% -$26M 0.98% 12
2025
Q2
$656M Buy
841,810
+100,088
+13% +$77.8M 1.11% 13
2025
Q1
$613M Buy
741,722
+9,172
+1% +$7.63M 1.13% 13
2024
Q4
$566M Sell
732,550
-96,832
-12% -$80.2M 0.99% 13
2024
Q3
$735M Buy
829,382
+1,701
+0.2% +$1.53M 1.3% 10
2024
Q2
$749M Sell
827,681
-1,399
-0.2% -$1.12M 1.39% 9
2024
Q1
$645M Sell
829,080
-95,208
-10% -$67.8M 1.22% 10
2023
Q4
$539M Sell
924,288
-33,842
-4% -$19.8M 1.12% 11
2023
Q3
$515M Buy
958,130
+22,710
+2% +$11.7M 1.17% 10
2023
Q2
$439M Sell
935,420
-252,773
-21% -$106M 0.95% 11
2023
Q1
$408M Buy
1,188,193
+206,551
+21% +$69.7M 0.92% 12
2022
Q4
$359M Buy
981,642
+82,765
+9% +$29.3M 0.86% 10
2022
Q3
$291M Sell
898,877
-217,791
-20% -$69M 0.72% 18
2022
Q2
$362M Buy
1,116,668
+133,910
+14% +$40.2M 0.83% 18
2022
Q1
$281M Sell
982,758
-25,000
-2% -$6.43M 0.53% 26
2021
Q4
$278M Sell
1,007,758
-169,408
-14% -$42.9M 0.5% 30
2021
Q3
$272M Buy
1,177,166
+365,640
+45% +$90.2M 0.54% 30
2021
Q2
$186M Sell
811,526
-68,812
-8% -$13.8M 0.36% 52
2021
Q1
$164M Buy
880,338
+482,487
+121% +$94.4M 0.34% 61
2020
Q4
$67.2M Buy
397,851
+64,000
+19% +$9.56M 0.15% 156
2020
Q3
$49.4M Buy
333,851
+121,200
+57% +$18.8M 0.12% 180
2020
Q2
$34.9M Sell
212,651
-655,400
-76% -$101M 0.09% 248
2020
Q1
$120M Buy
868,051
+646,490
+292% +$88.8M 0.36% 63
2019
Q4
$29.1M Sell
221,561
-196,700
-47% -$22.8M 0.07% 304
2019
Q3
$46.8M Buy
418,261
+65,500
+19% +$7.29M 0.11% 210
2019
Q2
$39.1M Sell
352,761
-727,345
-67% -$85.7M 0.1% 243
2019
Q1
$140M Sell
1,080,106
-113,019
-9% -$13.7M 0.35% 74
2018
Q4
$138M Sell
1,193,125
-33,190
-3% -$3.71M 0.38% 66
2018
Q3
$132M Sell
1,226,315
-443,075
-27% -$44.3M 0.29% 91
2018
Q2
$142M Buy
1,669,390
+75,990
+5% +$6.24M 0.33% 70
2018
Q1
$123M Sell
1,593,400
-83,870
-5% -$6.75M 0.29% 93
2017
Q4
$142M Buy
1,677,270
+290,775
+21% +$24.7M 0.32% 83
2017
Q3
$119M Sell
1,386,495
-284,400
-17% -$23.3M 0.29% 84
2017
Q2
$138M Sell
1,670,895
-396,300
-19% -$32.3M 0.34% 73
2017
Q1
$174M Buy
2,067,195
+4,900
+0.2% +$392K 0.44% 52
2016
Q4
$152M Sell
2,062,295
-264,200
-11% -$19.7M 0.41% 56
2016
Q3
$187M Buy
2,326,495
+673,790
+41% +$53.9M 0.51% 40
2016
Q2
$130M Sell
1,652,705
-175,445
-10% -$13.2M 0.36% 81
2016
Q1
$132M Sell
1,828,150
-71,150
-4% -$5.38M 0.36% 81
2015
Q4
$160M Sell
1,899,300
-168,700
-8% -$14M 0.42% 63
2015
Q3
$173M Sell
2,068,000
-523,200
-20% -$44.2M 0.48% 49
2015
Q2
$216M Buy
2,591,200
+850,000
+49% +$64.8M 0.54% 35
2015
Q1
$126M Buy
1,741,200
+104,000
+6% +$7.4M 0.31% 89
2014
Q4
$113M Sell
1,637,200
-215,400
-12% -$14.5M 0.28% 101
2014
Q3
$120M Sell
1,852,600
-770,400
-29% -$48.8M 0.3% 87
2014
Q2
$163M Buy
2,623,000
+496,200
+23% +$29.6M 0.42% 54
2014
Q1
$125M Buy
2,126,800
+1,202,300
+130% +$67.1M 0.34% 78
2013
Q4
$47.1M Sell
924,500
-300,000
-24% -$15M 0.12% 224
2013
Q3
$61.6M Buy
1,224,500
+1,213,200
+10,736% +$63.5M 0.18% 159
2013
Q2
$555K Buy
+11,300
New +$615K ﹤0.01% 670

Other funds holding LLY

Adage Capital Partners's LLY Position: Q1 2026 in Review

Adage Capital Partners increased its Eli Lilly (LLY) stake by 15% in Q1 2026, buying an estimated $126M and bringing the position to 956,817 shares worth $880M. The position accounts for 1.36% of the portfolio, ranked #10.

Adage Capital Partners first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $894M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Adage Capital Partners held 956,817 shares of Eli Lilly worth $880M as of Q1 2026.
  • Adage Capital Partners bought 124,525 Eli Lilly shares in Q1 2026, an estimated $126M.
  • Eli Lilly made up 1.36% of Adage Capital Partners's portfolio in Q1 2026, its #10 holding.
  • Adage Capital Partners first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • Adage Capital Partners's Eli Lilly position peaked at $894M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Adage Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.